Classifications

• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B82—NANOTECHNOLOGY
  • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
  • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
  • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
  • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
  • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
  • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
  • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
  • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
  • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
  • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
  • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
  • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
  • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
  • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
  • C07H9/04—Cyclic acetals

Landscapes

• Chemical & Material Sciences (AREA)
• Health & Medical Sciences (AREA)
• Organic Chemistry (AREA)
• Engineering & Computer Science (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Biotechnology (AREA)
• Molecular Biology (AREA)
• Biochemistry (AREA)
• Genetics & Genomics (AREA)
• Pharmacology & Pharmacy (AREA)
• Medicinal Chemistry (AREA)
• Nanotechnology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Animal Behavior & Ethology (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Epidemiology (AREA)
• Biophysics (AREA)
• Crystallography & Structural Chemistry (AREA)
• Medical Informatics (AREA)
• General Engineering & Computer Science (AREA)
• Oncology (AREA)
• Communicable Diseases (AREA)
• General Chemical & Material Sciences (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicines Containing Material From Animals Or Micro-Organisms (AREA)
• Medicinal Preparation (AREA)
• Steroid Compounds (AREA)
• Saccharide Compounds (AREA)

Applications Claiming Priority (2)

Publications (2)

Family

ID=25111545

Family Applications (1)

Country Status (27)

Families Citing this family (24)

Family Cites Families (18)

• 1992
  • 1992-10-14 AU AU27806/92A patent/AU678344B2/en not_active Ceased
  • 1992-10-14 EP EP92309368A patent/EP0538011B1/en not_active Expired - Lifetime
  • 1992-10-14 TW TW081108170A patent/TW221378B/zh active
  • 1992-10-14 CA CA002121345A patent/CA2121345C/en not_active Expired - Fee Related
  • 1992-10-14 AT AT92309368T patent/ATE156019T1/de not_active IP Right Cessation
  • 1992-10-14 PL PL92303189A patent/PL170591B1/pl unknown
  • 1992-10-14 DE DE69221252T patent/DE69221252T2/de not_active Expired - Fee Related
  • 1992-10-14 PH PH45109A patent/PH31675A/en unknown
  • 1992-10-14 ZA ZA927923A patent/ZA927923B/xx unknown
  • 1992-10-14 YU YU92192A patent/YU48722B/sh unknown
  • 1992-10-14 DK DK92309368.6T patent/DK0538011T3/da active
  • 1992-10-14 US US08/211,700 patent/US5624914A/en not_active Expired - Lifetime
  • 1992-10-14 WO PCT/US1992/008565 patent/WO1993007904A1/en not_active Application Discontinuation
  • 1992-10-14 ES ES92309368T patent/ES2104845T3/es not_active Expired - Lifetime
  • 1992-10-14 HU HU9401104A patent/HUT75157A/hu unknown
  • 1992-10-14 KR KR1019940701247A patent/KR100249584B1/ko not_active IP Right Cessation
  • 1992-10-14 EP EP92921991A patent/EP0610295A1/en active Pending
  • 1992-10-14 NZ NZ244735A patent/NZ244735A/en unknown
  • 1992-10-14 JP JP5507719A patent/JP2614407B2/ja not_active Expired - Lifetime
  • 1992-10-15 CN CN92112388A patent/CN1035923C/zh not_active Expired - Fee Related
  • 1992-10-15 IL IL10344692A patent/IL103446A/xx not_active IP Right Cessation
  • 1992-10-15 MX MX9205922A patent/MX9205922A/es not_active IP Right Cessation
  • 1992-10-16 SI SI19929200260A patent/SI9200260A/sl unknown
  • 1992-10-16 HR HR07/777,864A patent/HRP921069B1/xx not_active IP Right Cessation
• 1994
  • 1994-04-08 NO NO941276A patent/NO307326B1/no not_active IP Right Cessation
  • 1994-04-14 FI FI941723A patent/FI941723A/fi unknown
• 1997
  • 1997-09-19 GR GR970402434T patent/GR3024800T3/el unknown
• 1998
  • 1998-01-09 HK HK98100167A patent/HK1001085A1/xx not_active IP Right Cessation

Also Published As

Similar Documents